Amicus Therapeutics, Inc.

FOLD US03152W1099

🆔
Registration No.
3457447
💰
Capitalization
Mid-cap

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

🔗
Website
Annual Performance 1
2021 2022 2023 2024 2025
-47% 1% 19% -34% 1%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
45
🙍
Insiders
7
Person Price Shares Total Published Completed
Campbell Bradley L
CEO 		10.00
USD 		400
Sold 		4,000
USD 		19/02/2025 19/02/2025
Campbell Bradley L
CEO 		10.02
USD 		7,500
Sold 		75,125
USD 		02/12/2024 02/12/2024
Campbell Bradley L
CEO 		12.50
USD 		7,901
Sold 		98,800
USD 		06/11/2024 06/11/2024
Campbell Bradley L
CEO 		11.46
USD 		7,500
Sold 		85,960
USD 		01/11/2024 01/11/2024
Campbell Bradley L
CEO 		10.60
USD 		7,500
Sold 		79,493
USD 		01/10/2024 01/10/2024
Campbell Bradley L
CEO 		11.71
USD 		7,500
Sold 		87,798
USD 		03/09/2024 03/09/2024
Campbell Bradley L
CEO 		10.34
USD 		7,500
Sold 		77,519
USD 		01/08/2024 01/08/2024
Campbell Bradley L
CEO 		10.00
USD 		6,100
Sold 		61,029
USD 		05/07/2024 05/07/2024
Campbell Bradley L
CEO 		10.00
USD 		1,400
Sold 		14,003
USD 		01/07/2024 01/07/2024
Campbell Bradley L
CEO 		10.00
USD 		7,500
Sold 		75,000
USD 		03/06/2024 03/06/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Amicus Therapeutics, Inc. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-20% -8% -18% -25% -37% -32% 4%
Last 52W Low 52W High All-Time Low All-Time High β
8.16 5.64 8.69 5.64 8.69
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Crowley John F 10 3,019,825.27 301,982.53 01/11/2023 01/03/2024
Campbell Bradley L 19 1,770,421.97 93,180.10 01/11/2023 19/02/2025
Rosenberg Ellen 5 1,306,647.76 261,329.55 26/12/2023 07/02/2024
Prout Samantha 3 556,773.52 185,591.17 26/12/2023 09/01/2024
Castelli Jeff 3 506,444.80 168,814.93 19/12/2023 28/12/2023
Clark David Michael 3 203,518.00 67,839.33 08/01/2024 15/02/2024
Mcglynn Margaret G 2 200,175.00 100,087.50 04/03/2024 05/03/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.